IL22 and clostridium difficile infection: Closer examination of immune responses following CDI and AXPN treatment revealed striking differences in gene expression profiles between CDI and GF murine models, with induction of genes encoding IL-33 and factors in the IL-22 pathway requiring the presence of the microbiota.